Cargando…

Combined intra-arterial and intra-muscular transfer of Wharton’s jelly mesenchymal stem/stromal cells in no-option critical limb ischemia – CIRCULATE N-O CLI Pilot Study

INTRODUCTION: Despite progress in pharmacologic and revascularization therapies, no-option critical limb ischemia poses a major clinical and societal problem. Prior cell-based strategies involved mainly autologous (limited) cell sources. AIM: To evaluate the safety and feasibility of a novel ischemi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kwiatkowski, Tomasz, Zbierska-Rubinkiewicz, Katarzyna, Krzywon, Jerzy W., Majka, Marcin, Jarocha, Danuta, Kijowski, Jacek, Brzychczy, Andrzej, Musialek, Piotr, Trystula, Mariusz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2022
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10031676/ https://www.ncbi.nlm.nih.gov/pubmed/36967850 http://dx.doi.org/10.5114/aic.2022.120963

Ejemplares similares

Cellular therapies in no-option critical limb ischemia: present status and future directions
por: Kwiatkowski, Tomasz, et al.
Publicado: (2022)

Myocardial regeneration strategy using Wharton's jelly mesenchymal stem cells as an off-the-shelf ‘unlimited’ therapeutic agent: results from the Acute Myocardial Infarction First-in-Man Study
por: Musialek, Piotr, et al.
Publicado: (2015)

Acute myocardial infarction reparation/regeneration strategy using Wharton’s jelly multipotent stem cells as an ‘unlimited’ therapeutic agent: 3-year outcomes in a pilot cohort of the CIRCULATE-AMI trial
por: Kwiecien, Ewa, et al.
Publicado: (2022)

The Treasury of Wharton's Jelly
por: Guenther, Rebecca, et al.
Publicado: (2021)

AFM-based Analysis of Wharton’s Jelly Mesenchymal Stem Cells
por: Szydlak, Renata, et al.
Publicado: (2019)

Molecular and Functional Verification of Wharton’s Jelly Mesenchymal Stem Cells (WJ-MSCs) Pluripotency
por: Musiał-Wysocka, Aleksandra, et al.
Publicado: (2019)

Transient flow reversal combined with sustained embolic prevention in transcervical revascularization of symptomatic and highly-emboligenic carotid stenoses for optimized endovascular lumen reconstruction and improved peri- and post-procedural outcomes
por: Trystuła, Mariusz, et al.
Publicado: (2020)

Wharton’s jelly absence: a possible cause of stillbirth
por: Damasceno, Eduarda Bittencourt, et al.
Publicado: (2013)

Antibacterial and Immunomodulatory Properties of Acellular Wharton’s Jelly Matrix
por: Dubus, Marie, et al.
Publicado: (2022)

Comparative Analysis of the Results of Stroke Treatment With Multiple Administrations of Wharton’s Jelly Mesenchymal Stem Cells–Derived HE-ATMP and Standard Conservative Treatment: Case Series Study
por: Milczarek, Olga, et al.
Publicado: (2023)

Regenerative Potential of the Product “CardioCell” Derived from the Wharton’s Jelly Mesenchymal Stem Cells for Treating Hindlimb Ischemia
por: Musiał-Wysocka, Aleksandra, et al.
Publicado: (2019)

Effects of maternal obesity on Wharton’s Jelly mesenchymal stromal cells
por: Badraiq, Heba, et al.
Publicado: (2017)

The Immunomodulatory Potential of Wharton's Jelly Mesenchymal Stem/Stromal Cells
por: Vieira Paladino, Fernanda, et al.
Publicado: (2019)

Umbilical cord-derived Wharton’s jelly for regenerative medicine applications
por: Gupta, Ashim, et al.
Publicado: (2020)

Decellularization of Wharton’s Jelly Increases Its Bioactivity and Antibacterial Properties
por: Dubus, M., et al.
Publicado: (2022)

Nuclear magnetic resonance footprint of Wharton Jelly mesenchymal stem cells death mechanisms and distinctive in‐cell biophysical properties in vitro
por: Krzyżak, Artur T., et al.
Publicado: (2022)

Proteome analysis of human Wharton's jelly cells during in vitro expansion
por: Angelucci, Stefania, et al.
Publicado: (2010)

Wharton's jelly mesenchymal stem cells differentiate into retinal progenitor cells
por: Hu, Ying, et al.
Publicado: (2013)

Effects of Wharton’s jelly-derived mesenchymal stem cells on neonatal neutrophils
por: Khan, Imteyaz, et al.
Publicado: (2014)

Differentiation of Wharton's jelly mesenchymal stem cells into neurons in alginate scaffold
por: Hosseini, Seyed Mojtaba, et al.
Publicado: (2015)

Wharton’ jelly mesenchymal stromal cell therapy for ischemic brain injury
por: Wu, Kuo-Jen, et al.
Publicado: (2018)

Perinatal sources of mesenchymal stem cells: Wharton’s jelly, amnion and chorion
por: Witkowska-Zimny, Malgorzata, et al.
Publicado: (2011)

Abstract 126: Wharton’s Jelly Induces Osteogenesis In An Alveolar Cleft Model
por: Greives, Matthew R., et al.
Publicado: (2017)

Acellular Wharton’s Jelly, Potentials in T-Cell Subtypes Differentiation, Activation and Proliferation
por: Talebi, Mehdi, et al.
Publicado: (2020)

Isolation and Characterization of Feline Wharton’s Jelly-Derived Mesenchymal Stem Cells
por: Seo, Min-Soo, et al.
Publicado: (2021)

The Molecular Regulatory Mechanism in Multipotency and Differentiation of Wharton’s Jelly Stem Cells
por: Ma, Li, et al.
Publicado: (2023)

Mechanisms of Wharton’s Jelly-derived MSCs in enhancing peripheral nerve regeneration
por: Shin, Young Ho, et al.
Publicado: (2023)

Assessment of clinical, biochemical, and radiological outcomes following intra-articular injection of Wharton jelly-derived mesenchymal stromal cells in patients with knee osteoarthritis: A prospective clinical study
por: Günay, Ali Eray, et al.
Publicado: (2022)

Multiple Autologous Bone Marrow‐Derived CD271(+) Mesenchymal Stem Cell Transplantation Overcomes Drug‐Resistant Epilepsy in Children
por: Milczarek, Olga, et al.
Publicado: (2017)

Safety of intrathecal injection of Wharton’s jelly-derived mesenchymal stem cells in amyotrophic lateral sclerosis therapy
por: Barczewska, Monika, et al.
Publicado: (2019)

Learning PowerCLI
por: Nieuwendijk, Robert van den
Publicado: (2016)

PowerCLI cookbook
por: Sellers, Philip
Publicado: (2015)

C++/CLI in Action
por: Sivakumar, Nishant
Publicado: (2007)

Multi-modality imaging in the CIRCULATE-AMI pilot study cohort: a framework for an imaging-based randomized controlled trial of Wharton jelly mesenchymal stem cell use to stimulate myocardial repair/regeneration
por: Drabik, Leszek, et al.
Publicado: (2023)

The Intra-Muscular Method in the Treatment of Syphilis
Publicado: (1905)

Intra-Muscular Injection of Urea Stibamine
por: Kundu, S.
Publicado: (1925)

PowerCLI essentials: simplify and automate server administration tasks with PowerCLI
por: Halverson, Chris
Publicado: (2016)

Wharton’s jelly mesenchymal stem cells promote wound healing and tissue regeneration
por: Kamolz, Lars-Peter, et al.
Publicado: (2014)

Wharton's Jelly human Mesenchymal Stem Cell contact guidance by noisy nanotopographies
por: Jacchetti, E., et al.
Publicado: (2014)

Concise Review: Wharton's Jelly: The Rich, but Enigmatic, Source of Mesenchymal Stromal Cells
por: Davies, John E., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_0pcemgaja4ls12cmj3j3kugme7